ProfileGDS4718 / 227721_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 58% 56% 57% 58% 52% 56% 55% 59% 57% 57% 52% 55% 54% 50% 53% 60% 52% 55% 55% 55% 54% 56% 54% 54% 49% 56% 52% 63% 54% 55% 53% 58% 58% 53% 49% 57% 56% 60% 56% 56% 54% 52% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9798758
GSM549102patient 115, normal, homogenized [OPG study]6.0288958
GSM549104patient 119, normal, homogenized [OPG study]5.8607456
GSM549108patient 138, normal, homogenized [OPG study]5.9651757
GSM549119patient 077, normal, homogenized [OPG study]5.9769758
GSM549133patient 032, cancer, homogenized [OPG study]5.6125352
GSM549139patient 042, cancer, homogenized [OPG study]5.8559356
GSM549099patient 107, normal, homogenized [OPG study]5.8158155
GSM549109patient 139, normal, homogenized [OPG study]6.0606759
GSM549110patient 046, normal, homogenized [OPG study]5.9298857
GSM549114patient 063, normal, homogenized [OPG study]5.847557
GSM549122patient 082, normal, homogenized [OPG study]5.6383852
GSM549134patient 033, cancer, homogenized [OPG study]5.7926355
GSM549136patient 036, cancer, homogenized [OPG study]5.6848754
GSM549140patient 044, cancer, homogenized [OPG study]5.4714250
GSM549111patient 047, normal, homogenized [OPG study]5.7043653
GSM549113patient 057, normal, homogenized [OPG study]6.0633660
GSM549132patient 031, cancer, homogenized [OPG study]5.6183952
GSM549137patient 038, cancer, homogenized [OPG study]5.8085255
GSM549142patient 047, cancer, homogenized [OPG study]5.942955
GSM549100patient 110, normal, homogenized [OPG study]5.8320955
GSM549107patient 135, normal, homogenized [OPG study]5.6944154
GSM549115patient 068, normal, homogenized [OPG study]5.8194356
GSM549116patient 072, normal, homogenized [OPG study]5.7379954
GSM549120patient 078, normal, homogenized [OPG study]5.7492554
GSM549131patient 030, cancer, homogenized [OPG study]5.4060349
GSM549118patient 074, normal, homogenized [OPG study]5.8644856
GSM549129patient 027, cancer, homogenized [OPG study]5.6460652
GSM549123patient 088, normal, homogenized [OPG study]6.3540763
GSM549124patient 006, cancer, homogenized [OPG study]5.7780254
GSM549126patient 015, cancer, homogenized [OPG study]5.7855655
GSM549128patient 025, cancer, homogenized [OPG study]5.6790853
GSM549103patient 117, normal, homogenized [OPG study]6.0225758
GSM549117patient 073, normal, homogenized [OPG study]5.9264358
GSM549138patient 041, cancer, homogenized [OPG study]5.6967753
GSM549141patient 045, cancer, homogenized [OPG study]5.4211249
GSM549130patient 028, cancer, homogenized [OPG study]5.9033757
GSM549101patient 111, normal, homogenized [OPG study]5.9159256
GSM549105patient 128, normal, homogenized [OPG study]6.1382960
GSM549106patient 134, normal, homogenized [OPG study]5.8160756
GSM549112patient 048, normal, homogenized [OPG study]5.8882156
GSM549125patient 011, cancer, homogenized [OPG study]5.721654
GSM549127patient 024, cancer, homogenized [OPG study]5.6545452
GSM549135patient 035, cancer, homogenized [OPG study]5.8879657